Transthyretin Cardiac Amyloidosis Fellowship seeks to promote the importance of training healthcare professionals to recognize, diagnose and manage ATTR cardiac amyloidosis and to foster research in this field.
Donor Name: Pfizer
State: All States
County: All Counties
Type of Grant: Fellowship
Deadline: 05/06/2026
Size of the Grant: $10,000 to $100,000
Grant Duration: 1 Year
Details:
Project Types and Area of Interest
It is intent to support institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis.
Funding Information
Grant funding is available to support a one year fellowship up to $80,000.00.
Geographic Scope
United States
Eligibility Criteria
- Accredited, US-based academic institution.
- Do not include the name of the potential fellow(s) in application materials. This grant will be awarded to an institution, not an individual.
- Institutions with fellowship programs that include independent research and a strong mentoring program. Clinical training may be included in the program but is not required.
- No aspect of the fellowship program can benefit Pfizer’s business or a Pfizer asset.
- Examples of independent research include: observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; use of screening tools and their impact on improvement of patient health.
- Examples of research that would not be eligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, in-vitro, etc.).
- Examples of clinical training include: educational time with an interdisciplinary team in review of case examples and relevant didactic training as well as use of tools for improvement in patient health for specific therapeutic areas or conditions.
- Fellow time spent in the clinical setting that is supported through grant funds must not be billed as patient care.
For more information, visit Pfizer.
